Wednesday, February 16, 2011

Genzyme = Done Deal

Well, it’s about time… Genzyme (Ticker: GENZ) has finally agreed to be acquired by Sanofi-Aventis (Ticker: SNY) for $74 in cash plus CVR (the maximum value of the CVR will be $14 in the best case scenario). I’m going to hang on to the shares until closing so I get the CVR’s. It’s been a fun and profitable journey. The game's not over and now it’s time to search for the next big trade…


At February 17, 2011, Anonymous DCFrancis said...

hey very good call.


Post a Comment

<< Home